Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Histidine–tryptophan–ketoglutarate (HTK) cardioplegia for myocardial protection obviates the need for maintenance cardioplegia doses, and thus allows for greater focus on procedure accuracy. The aim of this meta‐analysis is to evaluate the safety and efficacy of HTK versus multidose cardioplegias during cardiac surgery in an adult population.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Electronic searches were performed using PubMed, Science Direct, and Google Scholar databases. The key search terms included HTK cardioplegia AND cardiac surgery AND adult. This was followed by a meta‐analysis investigating cardiopulmonary bypass (CPB) duration, cross‐clamp duration, spontaneous defibrillation, inotropic support, mortality, atrial fibrillation, creatine kinase muscle brain band (CK‐MB) and troponin I (TnI).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Seven randomized controlled trials (<i>n</i> = 804) were analyzed. Spontaneous defibrillation following aortic cross‐clamp removal significantly favored HTK (odds ratio [OR], 2.809; 95% confidence interval [CI], 1.574 to 5.012; <i>I</i><sup>2</sup> = 0%; <i>p</i> < .01). There were no other notable significant differences between HTK and multidose cardioplegia in any of the parameters measured. In particular, the OR for mortality was 1.237 (95% CI, 0.385 to 3.978; <i>I</i><sup>2</sup> = 0%; <i>p</i> = .721) and the mean difference for CPB duration overall was 2.072 min (95% CI, −2.405 to 6.548; <i>I</i><sup>2</sup> = 74%; <i>p</i> = .364). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>HTK is safe and effective during adult cardiac surgery when compared with multidose cardioplegias for myocardial protection during surgical correction of acquired pathology in the adult population. HTK may, therefore, be suitable for complex cases or those of extensive duration, without the prospect of increased postoperative morbidity or mortality.</p></section>

HTK Solution Cardioplegia in Pediatric Patients: A Meta-analysis

HTK versus multidose cardioplegias for myocardial protection in adult cardiac surgery: A meta‐analysis

Myocardial protection study of histidine-tryptophan-ketoglutarate cardioplegic solution on infants with tetralogy

A Network Comparison of Del Nido, Histidine-Tryptophan-Ketoglutarate, and Blood Cardioplegia

Effect of Cardioplegia for Myocardial Protection in Pediatric Cardiac Surgery: A Network Meta-Analysis

Comparable prognosis in different neonatal histidine-tryptophan-ketoglutarate dosage management

Influence of cardioplegic solution on incidence of acute kidney injury after coronary artery bypass surgery procedure: del Nido cardioplegia versus Histidine‐Tryptophan‐Ketoglutarate solution: Insight of kidney disease improving global outcomes criteria

The Potential Neurological Impact of Intraoperative Hyponatremia Using Histidine-Tryptophan-Ketoglutarate Cardioplegia Infusion in Adult Cardiac Surgery

Effects of Custodial Histidine-Triptophan-Ketoglutalate Solution on Myocardial Protection in Infants' Open Heart Surgery

Comparison of Del Nido and histidine-tryptophan-ketoglutarate cardioplegia solutions: an animal study with prolonged ischaemia

Role of terminal warm blood cardioplegia in complex congenital heart surgery

Histidine-trytophan-ketoglutarate cardioplegia reduces inflammatory response and serum levels of myocardial enzymes in newly developed right-thoracotomy rat model

Myocardial Protection in Donor Heart Preservation: A Comparison Between Bretschneider's Histidine–Tryptophan–Ketoglutarate Solution and Cold Blood Cardioplegia

Application of thromboelastography for children undergoing cardiac surgery with cardiopulmonary bypass

Del Nido versus HTK cardioplegia for myocardial protection during adult complex valve surgery: a retrospective study

Clinical outcomes of single-dose cardioplegia in high-risk coronary bypass

Efficacy of Therapeutic Plasma Exchange or Cangrelor as an Adjunctive Strategy to Facilitate Cardiopulmonary Bypass in Patients with Heparin-Induced Thrombocytopenia: A Systematic Review and Meta-Analysis

Comparison of myocardial protection effect of HTK with cold blood cardioplegia on severe valvular heart disease

Therapeutic Hypothermia for Cardiac Arrest Due to Non-Shockable Rhythm

Comparative outcomes of cardioplegic arrest versus beating heart in pediatric undergoing extracardiac total cavopulmonary connection

del Nido cardioplegia better preserves cardiac diastolic function but histidine–tryptophan–ketoglutarate is better for endothelial function